top of page

THERAPEUTIC GOODS REGULATION

TGA & Therapeutic Goods Compliance Consultant Australia

Specialist regulatory and compliance support for organisations navigating Australia's therapeutic goods advertising, regulatory compliance, import and supply environment.

Advertising | Compliance | Investigations | Import & Supply | Regulatory Response

Navigating Australia's Therapeutic Goods Regulatory Environment

Australia's therapeutic goods regulatory framework imposes detailed requirements on organisations involved in the advertising, promotion, import and supply of therapeutic goods. Regulatory concerns can arise from advertising claims, digital and social media content, product promotion, importation, supply arrangements and broader compliance practices.

IntegriRisk provides specialist regulatory and compliance advisory support to organisations seeking to understand potential compliance issues, assess conduct and evidence, respond to regulatory concerns and strengthen their compliance systems. Where a matter requires legal interpretation or legal representation, organisations should obtain advice from an appropriately qualified legal practitioner. IntegriRisk's role is regulatory, investigative and operational advisory.

Therapeutic Goods Advertising Compliance

Advertising therapeutic goods in Australia requires careful consideration of both the product and the nature of the promotional conduct. Websites, social media, digital campaigns, testimonials, influencer content and other communications may raise therapeutic goods advertising issues depending on their content and context. IntegriRisk can assist organisations to review advertising and promotional conduct, identify potential compliance risks and strengthen internal processes for reviewing therapeutic goods advertising.

advertising and promotional content reviews

websites and digital marketing

social media advertising and promotion
therapeutic claims and representations
internal advertising approval processes
advertising compliance frameworks
identification and assessment of potential non-compliance
remediation and compliance improvement

Responding to TGA Compliance Concerns

Receiving correspondence or enquiries from a regulator can require an organisation to quickly understand the issues raised, identify relevant evidence and determine an appropriate response. IntegriRisk can provide regulatory and investigation support to organisations responding to concerns raised in relation to therapeutic goods advertising, import, supply or other regulated conduct.

Initial Regulatory Assessment

Understand the issues raised, relevant conduct and available information.

Evidence & Information Review

Identify and assess relevant advertising, communications, records and other material.

Conduct Review

Establish what occurred and identify potential areas requiring further assessment or remediation.

Regulatory Response Support

Assist the organisation to organise relevant factual and compliance information required to respond to regulatory engagement.

Remediation

Identify practical changes to advertising, processes, controls or compliance systems.

Ongoing Compliance

Strengthen governance and processes to reduce future regulatory risk.

Where regulatory correspondence raises legal issues, potential liability or formal enforcement action, IntegriRisk can work alongside the organisation's legal advisers while providing specialist regulatory, factual and operational support.

Import & Supply Compliance

Therapeutic goods regulation extends beyond advertising. Organisations involved in importing, supplying or distributing regulated products may also encounter complex regulatory requirements and potential compliance concerns. IntegriRisk can assist organisations to review relevant conduct, processes, documentation and compliance systems where concerns arise in relation to the import or supply of regulated products.

Medicinal Cannabis Compliance

Medicinal cannabis operates within a particularly sensitive advertising and regulatory environment. Businesses involved in medicinal cannabis, prescribing services, clinics, digital platforms or related services need to carefully consider how products and services are promoted to the public. IntegriRisk can assist organisations to review advertising and promotional practices, identify potential compliance concerns, assess relevant conduct and strengthen internal compliance processes.

Medicinal Cannabis Advertising in Australia: Key Compliance Considerations

Vaping Goods Compliance

Australia's vaping reforms have created a highly regulated environment for the import, supply, advertising and promotion of vaping goods. IntegriRisk can provide specialist regulatory and compliance support in relation to advertising and promotional conduct, supply-related concerns, compliance processes and regulatory engagement involving vaping goods.

advertising and promotion

websites and social media

supply-related compliance concerns

review of relevant conduct and evidence

regulatory response support

remediation and compliance systems

Vape Advertising in Australia: Understanding the Advertising Restrictions

Compliance Systems & Remediation

Regulatory compliance should not depend solely on responding after an issue arises. Organisations can reduce regulatory risk by establishing clear systems for identifying, reviewing and escalating potential compliance issues. IntegriRisk can assist organisations to develop or strengthen:

advertising review and approval processes

compliance policies and procedures

risk assessment processes

escalation pathways

compliance monitoring

record keeping

internal guidance

staff capability and training

remediation plans

bottom of page